Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors

By Joshi Ashish V.   Stephens Jennifer M.   Munro Vicki   Mathew Prasad   Botteman Marc F.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

GlycoPEGylated rFVIIa (N7‐GP) has a prolonged hemostatic effect in hemophilic mice compared with rFVIIa

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 1070-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor VIII Inhibitors in Patients with Hemophilia A

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

The Efficacy of Neurodevelopmental Treatment in Paediatrics: a Systematic Review

By Brown G Ted   Burns Scott A  

The British Journal of Occupational Therapy, Vol. 64, Iss. 5, 2001-05 ,pp. : 235-244

College of Occupational Therapists

Access to resources Recommend Favorite

Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 98, Iss. 2, 2016-08 ,pp. : 198-204

Karger

Access to resources Recommend Favorite